专利号:US-2023182202-A1 优先权日:2020-05-22 标 题:Nanoparticles and methods of making nanoparticles 发明人:WEI WEI DAVID; GUO WENXIAO 权利人:UNIV FLORIDA 摘要:The present disclosure provides for metal nanoparticles, such as gold nanoparticles that have six pointed areas so that the metal nanoparticle resembles a six-pointed star. The distance from opposing points of the six-pointed star is about 400 to 480 nanometers. The present disclosure also provides for a method of making the nanoparticle, where in an aspect, the method is a light-driven synthesis.
专利号:US-12226754-B2 优先权日:2020-12-30 标题:Method to produce high densities of isolated atoms on support substrates 发明人:SHAKOURI ABOLFAZL; ADABI FIROUZJAIE HORIE; REGALBUTO JOHN R; WILLIAMS CHRISTOPHER T; MUSTAIN WILLIAM E 权利人:UNIV SOUTH CAROLINA 摘要:Described herein is a general scalable synthesis method for a high density of single metal atoms in a supported catalyst, supported isolated atoms featuring unique reactivity and the support materials determine the stability, electronic properties, and local environment which can be adjusted for targeted heterogeneous catalysis applications.
专利号:WO-2024044510-A2 优先权日:2022-08-22 标题:Direct synthesis of two-dimensional carbide and nitride mxenes
专利号:TW-200811122-A 优先权日:2006-03-27 标题:A convergent process for the synthesis of taxane derivatives
专利号:US-11285169-B2 优先权日:2013-03-13 标题 :Methods for modulating chemotherapeutic cytotoxicity 发明人:ROBERTS DAVID D; SOTO PANTOJA DAVID R 权利人:US HEALTH 摘要:Methods of reducing cytotoxicity of a chemotherapeutic agent to non-cancer cells by administering to a subject with cancer an effective amount of an agent that inhibits CD47 signaling and a DNA damaging agent, such as an anthracycline, topoisomerase inhibitor, or nucleotide synthesis inhibitor, are provided. Example disclosed methods reduce cardiotoxicity. In one example, the methods include administering to a subject with cancer an effective amount of a CD47 antisense morpholino oligonucleotide and an anthracycline such as doxorubicin. Methods of increasing cytotoxicity of a chemotherapeutic agent in cancer cells by administering to a subject with a tumor an effective amount of an agent that inhibits CD47 signaling and a DNA damaging agent such as an anthracycline, topoisomerase inhibitor, or nucleotide synthesis inhibitor, are also provided. In some embodiments, the inhibitor of CD47 signaling is administered to the subject before, during, or after the administration of the DNA damaging agent.
专利号:WO-2024178062-A1 优先权日:2023-02-21 标 题 :Deagglomeration by transient salt liquids for the synthesis or recycling of battery cathodes
1: Ghorbani A, Amiri MS, Hosseini A. Pharmacological properties of Rheum turkestanicum Janisch. Heliyon. 2019 Jun 23;5(6):e01986. doi: 10.1016/j.heliyon.2019.e01986. 2: Ulus G. Antiangiogenic properties of lichen secondary metabolites. Phytother Res. 2021 Jun;35(6):3046-3058. doi: 10.1002/ptr.7023. Epub 2021 Feb 15. 12:638993. doi: 10.3389/fphar.2021.638993.
合成参考文献
参考文献:10.1055/s-2005-864190 摘要:Ge HM, Song YC, Shan CY, Ye YH, Tan RX. New and cytotoxic anthraquinones from Pleospora sp. IFB-E006, an endophytic fungus in Imperata cylindrical. Planta Med. 2005 Nov;71(11):1063–5. doi: 10.1055/s-2005-864190. 参考文献:10.3390/molecules16075928 摘要:Zhao LC, Liang J, Li W, Cheng KM, Xia X, Deng X, Yang GL. The use of response surface methodology to optimize the ultrasound-assisted extraction of five anthraquinones from Rheum palmatum L. Molecules. 2011 Jul 15;16(7):5928–37.